| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66556f5aefeabccab0e23efea5d923c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_823e64d113acc4303f53fbcf25fc366e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a343dcbe7368f3f7255247c05f24047f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2004-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef5b2f983330a01d772543bf43e90c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b5ae26e9069844b0bfb05c7c952582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886bc52b4c08c41c8e9616bf72e6c5fd |
| publicationDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006147388-A1 |
| titleOfInvention |
Pharmaceutical compositions for nasal delivery |
| abstract |
According to the invention there is provided a powdered pharmaceutical formulation suitable for nasal delivery which is a freeze-dried blend of active material and excipient(s) containing: 0.5-50% by wt of active material 50-99.5% by wt of excipient(s), and in which at least 0.1% by wt of the blend is an amorphous state, which can be directly obtained by freeze drying without the need for milling and without containing the pronounced low particles defined as finings. Such powders retain free-flowing properties on storage, are physically and chemically stable and are readily soluble. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019275036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015044782-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022009248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2581431-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4008307-A1 |
| priorityDate |
2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |